We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Darling Ingredients Benefiting From Rising Health Food Demand Trends?
Read MoreHide Full Article
Key Takeaways
Darling Ingredients' Food Ingredients sales rose 16% to $405.2M in Q1 fiscal 2026.
DAR cited stronger collagen and gelatin demand across Europe and Asia for growth.
DAR said collagen and gelatin margins remained favorable globally in its Rousselot business.
Darling Ingredients Inc.’s (DAR - Free Report) food segment is increasingly benefiting from the global shift toward preventive health and functional nutrition, particularly through rising demand for collagen-based products. In the first quarter of fiscal 2026, the Food Ingredients segment generated $405.2 million in sales, up 16% from $349.2 million a year earlier, while segment adjusted EBITDA increased to $80.8 million from $70.9 million. Management attributed part of the improvement to stronger collagen and gelatin demand across Europe and Asia.
The company said collagen and gelatin sales improved year over year due to expanding applications in food, nutrition and health products. Darling Ingredients also noted that its Rousselot business continues to see favorable collagen and gelatin margins globally. The trend aligns with broader consumer demand for high-protein, wellness-focused products targeting healthy aging, mobility and active lifestyles.
A key growth initiative is Nextida, Darling Ingredients’ glucose-control ingredient aimed at metabolic health. Management said the product is currently awaiting U.S. patent approvals tied to production processes and its use as a dietary supplement ingredient designed to help lower blood glucose levels. The company positioned the product as a non-pharmaceutical alternative benefiting from rising interest in “food as medicine.”
The strategy could expand Darling Ingredients’ presence beyond commodity ingredients into higher-value specialty nutrition categories. As consumers increasingly seek functional foods with measurable health benefits, the company’s collagen portfolio and specialty ingredient pipeline are becoming more important growth drivers within its food business.
What Do the Latest Metrics Say About Darling Ingredients?
Darling Ingredients, which competes with Tyson Foods Inc. (TSN - Free Report) and Ingredion Inc. (INGR - Free Report) , has seen its shares rally 82.8% in the past year against the industry’s 27.6% decline. Shares of Tyson Foods have risen 17.4%, while Ingredion has declined 26.7% during the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, Darling Ingredients’ forward 12-month price-to-earnings ratio stands at 13x, slightly lower than the industry’s 13.4x. The company is trading at a discount to Tyson Foods (with a forward 12-month P/E ratio of 14.75x) while trading at a premium to Ingredion (9.16x).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Darling Ingredients’ current fiscal-year sales and earnings per share implies year-over-year growth of 12.3% and 588.2%, respectively.
View the Zacks #1 Rank List
Image: Bigstock
Darling Ingredients Benefiting From Rising Health Food Demand Trends?
Key Takeaways
Darling Ingredients Inc.’s (DAR - Free Report) food segment is increasingly benefiting from the global shift toward preventive health and functional nutrition, particularly through rising demand for collagen-based products. In the first quarter of fiscal 2026, the Food Ingredients segment generated $405.2 million in sales, up 16% from $349.2 million a year earlier, while segment adjusted EBITDA increased to $80.8 million from $70.9 million. Management attributed part of the improvement to stronger collagen and gelatin demand across Europe and Asia.
The company said collagen and gelatin sales improved year over year due to expanding applications in food, nutrition and health products. Darling Ingredients also noted that its Rousselot business continues to see favorable collagen and gelatin margins globally. The trend aligns with broader consumer demand for high-protein, wellness-focused products targeting healthy aging, mobility and active lifestyles.
A key growth initiative is Nextida, Darling Ingredients’ glucose-control ingredient aimed at metabolic health. Management said the product is currently awaiting U.S. patent approvals tied to production processes and its use as a dietary supplement ingredient designed to help lower blood glucose levels. The company positioned the product as a non-pharmaceutical alternative benefiting from rising interest in “food as medicine.”
The strategy could expand Darling Ingredients’ presence beyond commodity ingredients into higher-value specialty nutrition categories. As consumers increasingly seek functional foods with measurable health benefits, the company’s collagen portfolio and specialty ingredient pipeline are becoming more important growth drivers within its food business.
What Do the Latest Metrics Say About Darling Ingredients?
Darling Ingredients, which competes with Tyson Foods Inc. (TSN - Free Report) and Ingredion Inc. (INGR - Free Report) , has seen its shares rally 82.8% in the past year against the industry’s 27.6% decline. Shares of Tyson Foods have risen 17.4%, while Ingredion has declined 26.7% during the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, Darling Ingredients’ forward 12-month price-to-earnings ratio stands at 13x, slightly lower than the industry’s 13.4x. The company is trading at a discount to Tyson Foods (with a forward 12-month P/E ratio of 14.75x) while trading at a premium to Ingredion (9.16x).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Darling Ingredients’ current fiscal-year sales and earnings per share implies year-over-year growth of 12.3% and 588.2%, respectively.
Darling Ingredients currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.